1. Home
  2. HAS vs VTRS Comparison

HAS vs VTRS Comparison

Compare HAS & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$81.18

Market Cap

11.1B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.96

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
VTRS
Founded
1923
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
12.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HAS
VTRS
Price
$81.18
$10.96
Analyst Decision
Strong Buy
Hold
Analyst Count
11
6
Target Price
$88.55
$11.17
AVG Volume (30 Days)
1.6M
7.9M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
3.45%
4.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,357,000,000.00
$14,124,400,000.00
Revenue This Year
$10.26
N/A
Revenue Next Year
$6.23
$1.16
P/E Ratio
N/A
N/A
Revenue Growth
0.79
N/A
52 Week Low
$49.00
$6.85
52 Week High
$83.45
$13.13

Technical Indicators

Market Signals
Indicator
HAS
VTRS
Relative Strength Index (RSI) 59.01 60.39
Support Level $81.24 $10.67
Resistance Level $83.38 $10.93
Average True Range (ATR) 1.77 0.24
MACD 0.19 0.01
Stochastic Oscillator 73.01 90.23

Price Performance

Historical Comparison
HAS
VTRS

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: